Insmed Incorporated

Gossamer Bio

This biopharmaceutical company develops inhaled therapies for patients suffering from pulmonary arterial hypertension and interstitial lung disease.

SpringWorks Therapeutics

This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.

Alnylam Pharmaceuticals

This biopharmaceutical company develops and commercialises RNA interference therapeutics to treat patients with rare, genetic, cardio-metabolic, and infectious diseases.

Ultragenyx

This biopharmaceutical company develops and commercialises therapies for patients with serious rare and ultra-rare genetic diseases.

Horizon Pharma

This company develops and commercialises medicines for patients with rare, autoimmune and severe inflammatory diseases.

Verona Pharma

This biopharmaceutical company develops and commercialises inhaled medicines to treat chronic respiratory diseases for adult patients with conditions such as chronic obstructive pulmonary disease.

Harmony Biosciences

This pharmaceutical company develops and commercialises therapies for patients living with rare neurological diseases, such as narcolepsy and other sleep-wake disorders.

Avalyn Pharma

The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.